12 / 88
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 4, July/August 2017
214
AFRICA
One limitation of the study is that the new echocardiographic
features reported in this study, namely endocardial fibrous
shelf and endomyocardiopericarial fibrosis, were collected
from a largely descriptive and small study, This needs further
verification, which can only be achieved in a large study.
Conclusion
This study confirmed that isolated cases of EMF are still seen in
Sudan. The main features of EMF were apical and ventricular
wall fibrosis, atrial enlargement and obliterated ventricles. New
details on endomyocardial pericardial layering and images of
endocardial fibrous shelf are described. A new echocardiographic
entity, EMPF, an advanced form of EMF that behaves like
constrictive pericarditis, was identified. Diagnosis of EMF
needed a high index of suspicion to differentiate it from other
conditions discussed in this article.
As the time course of the study may suggest, many doctors, nurses and medi-
cal records staff have provided assistance during the preparation, collection
and recording of this work. We are grateful for their help and support. We
thank Dr Sally Khalil for copy editing the manuscript.
References
1.
Lofler W. Endocarditis parietalis fibroplastica mit Bluteosinophilie:
ein eingenartiges Krankheitsbild.
Schweizer medizin Wochensch
1936;
17
: 817.
2.
Bedford DE, Konstam GLS. Heart failure of unknown aetiology in
Africans.
Br Heart J
1946;
8
: 236.
3.
Davies JNP. Endomyocardial fibrosis in Africans.
East Afr Med J
1948;
25
: 10–17.
4.
Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of
cardiomyopathy in Africa.
Circulation
2005;
112
(23): 3577–3583.
5.
Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study
of endomyocardial fibrosis in a rural area of Mozambique.
N Engl J
Med
2008;
359
: 43–49.
6.
Rashwan MA, Ayman M, Ashour S, Hassanin MM, Ziena AA.
Endomyocardial fibrosis in Egypt.
Br Heart J
1995;
73
(3): 284–289.
7.
Mocumbi AOH, Falase AO. Recent advances in the epidemiology, diag-
nosis and treatment of endomyocardial fibrosis in Africa.
Heart
2013;
99
: 1481–1487.
8.
Damasceno A, Mayosi BM,
et al
. The Sub-Saharan Africa Survey
of Heart Failure (THESUS-HF).
Arch Intern Med
2012;
172
(18):
1386–1394.
9.
Guimarães AC, Esteves JP, Filho AS, Macedo V. Clinical aspects of
endomyocardial fibrosis in Bahia, Brazil.
Am Heart J
1971;
81
: 7–19.
10. Vijayaraghavan G, Sivasankaran S. Tropical endomyocardial fibrosis in
India: A vanishing disease.
Indian J Med Res
2012;
136
: 729–738.
11. Yin R. Endomyocardial fibrosis in China.
Chin Med Sci J
2000;
15
:
55–60.
12. Niino T, Shiono M,
et al
. A case of left ventricular endomyocardial
fibrosis.
Ann Thorac Cardiovasc Surg
2002;
8
: 173–176.
13. Patel AK, D’Arbela PG, Somers K. Endomyocardial fibrosis and
eosinophilia.
Br Heart J
1977;
39
: 238–241.
14. Oakley CM, Olsen EGJ. Eosinphilia and heart disease.
Br Heart J
1977;
39
: 233–237.
15. Andy JJ, Bishara FF, Soyinka OO. Relation of severe eosinophilia and
microfilariasis to chronic African endomyocardial fibrosis.
Br Heart J
1981;
45
: 672–680.
16. Smedema JP, Stephan K, Winckels G,
et al
. Tropical endomyocardial
fibrosis (Davies’ disease): case report demonstrating the role of magnetic
resonance imaging.
Int J Cardiovasc Imag
2004;
20
: 517–522.
17. Oliveira SA, Barreto AC, Mady C. Surgical treatment of EMF, a new
approach.
J Am Coll Cardiol
1990;
16
: 1246–1251.
18. O’Brien W. Endocardial fibrosis in the Sudan.
Br Med J
1954;
2
:
899–903.
19. El Hassan AM, Wasfi AI. Cardiovascular disease in Khartoum: Post-
mortem and clinical evidence.
Trop Geogr Med
1972;
24
: 118–123.
20. Lang RM, Luigi P. Badano LP, Mor-Avi V, Afilalo J, Armstrong A,
Ernande L,
et al
. Recommendations for Cardiac Chamber Quantification
by Echocardiography in Adults: An Update from the American Society
of Echocardiography and the European Association of Cardiovascular
Imaging.
J Am Soc Echocardiogr
2015;
28
: 1–39.
21. Jae K Oh, Seward JB, Tajik AJ. No Normal heart chamber measure-
ment by two-dimensional echocardiography. In:
The Echo Manual
.
Philadelpia: Lippincott Williams & Wilkins, 1999.
22. Aquataella H, Shiller N, Puigbo JJ, Gomez-Mancebo, Suarez C,
Aquatella G. Value of two-dimensional echocardiography in endomyo-
cardial disease with and without eosinophilia: a clinical and pathologic
study.
Circulation
1983;
67
: 1219–1226.
23. Hassan WM, Fawzy ME. Pitfalls in diagnosis and clinical, echocardio-
graphic and hemodynamic findings in endomyocardial fibrosis.
Chest
2005;
128
; 3985–3992.
24. Davies JNP, Ball JD. The pathology of endomyocardial fibrosis in
Uganda.
Br Heart J
1955;
17
: 337–359.
25. Dave T, Narula JP, Chopra P. Myocardial and endocardial involvement
in tuberculous constrictive pericarditis: difficulty in biopsy distinction
from endomyocardial fibrosis as a cause of restrictive heart disease.
Int
J Cardiol
1990;
28
: 245–251.
26. Fawzy ME, Ziady G, Halim NM,
et al
. Endomyocardial fibrosis: report
of eight cases.
J Am Coll Cardiol
1985;
5
: 983–988.